Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
20%
OVERLAP
BY WEIGHT
3
# OF OVERLAPPING
HOLDINGS
IHE
55
HOLDINGS
7%
ALSO IN OZEM
OZEM
22
HOLDINGS
14%
ALSO IN IHE
SECTOR DRIFT (IHE minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 23.5% | 15.3% | 15.3% |
|
PFIZER INC | 4.3% | 4.0% | 4.0% |
|
WAVE LIFE SCIENCES LTD. | 0.5% | 0.8% | 0.5% |
IHE Overweight Relative to OZEM
|
JOHNSON & JOHNSON | 21.7% |
|
ELI LILLY & CO | 8.1% |
|
MERCK & CO. INC. | 5.0% |
|
BRISTOL-MYERS SQUIBB CO | 4.8% |
|
ZOETIS INC | 4.7% |
|
ROYALTY PHARMA PLC CLASS A | 4.1% |
|
VIATRIS, INC. | 4.0% |
|
ELANCO ANIMAL HEALTH, INC. | 3.2% |
 |
JAZZ PHARMACEUTICALS PLC | 2.6% |
|
AXSOME THERAPEUTICS, INC. | 1.9% |
IHE Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -22.0% |
 |
ROCHE HOLDING LTD | -4.2% |
|
ZEALAND PHARMA A/S | -3.9% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.9% |
|
VIKING THERAPEUTICS, INC. | -3.9% |
 |
ASCLETIS PHARMA, INC. | -3.6% |
 |
INNOVENT BIOLOGICS, INC. | -3.6% |
|
AMGEN INC | -3.5% |
 |
HANMI PHARM CO LTD | -3.4% |
|
SHANGHAI FOSUN PHARMACEUTI-H | -3.3% |